AbCellera Biologics Inc.ABCLNASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank43
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P43
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-20.95%
2024-147.41%
2023-115.82%
202213.40%
2021977.94%
2020742.24%
2019-24.43%
20180.00%